Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $37,971,214 |
Sells | 154 | $129,802,666 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 3,847 | 45.4534 | 174,859 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 15 Nov 2022 | Sale | 3,138 | 45.0423 | 141,343 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 100 | 39.96 | 3,996 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 4,900 | 39.41 | 193,109 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 500 | 44.02 | 22,010 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 8,900 | 43.47 | 386,883 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 600 | 42.15 | 25,290 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 869 | 41.1204 | 35,734 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 22,096 | 40.279 | 890,005 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 800 | 41.1204 | 32,896 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 20,338 | 40.279 | 819,194 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 4,013 | 43.2321 | 173,490 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 23,719 | 42.0299 | 996,907 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 44,440 | 41.1156 | 1,827,177 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 3,693 | 43.2321 | 159,656 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 21,830 | 42.0299 | 917,513 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 40,903 | 41.1156 | 1,681,751 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 20,085 | 44.9002 | 901,821 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 12,537 | 43.9749 | 551,313 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 38,961 | 43.0756 | 1,678,268 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 18,486 | 44.9002 | 830,025 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 11,539 | 43.9749 | 507,426 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 35,860 | 43.0756 | 1,544,691 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,906 | 44.9163 | 220,359 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,515 | 44.9163 | 202,797 | D |
27 Oct 2022 21:25 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 25 Oct 2022 | Sale | 12,500 | 44.7155 | 558,944 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 26 Oct 2022 | Sale | 4,762 | 45.03 | 214,433 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 25 Oct 2022 | Sale | 10,653 | 45.0905 | 480,349 | D |
27 Oct 2022 21:23 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2022 | Sale A | 22,500 | 29.18 | 656,550 | D |
17 Oct 2022 17:40 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Oct 2022 | Sale | 20,000 | 39.82 | 796,400 | D |
12 Oct 2022 16:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Oct 2022 | Sale | 5,000 | 37.99 | 189,950 | D |
07 Oct 2022 18:00 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 06 Oct 2022 | Sale | 22,500 | 39.29 | 884,025 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 100 | 34.39 | 3,439 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 5,350 | 33.57 | 179,600 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 4,550 | 32.8 | 149,240 | D |
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 34.06 | 766,350 | D |
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 31.38 | 706,050 | D |
15 Sep 2022 19:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 13 Sep 2022 | Sale | 43,204 | 27.69 | 1,196,319 | D |
15 Sep 2022 19:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 13 Sep 2022 | Sale | 16,796 | 26.74 | 449,125 | D |
15 Sep 2022 19:56 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2022 | Sale | 22,500 | 29.18 | 656,550 | D |
15 Sep 2022 19:57 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Sep 2022 | Sale | 13,580 | 27.87 | 378,475 | D |
15 Sep 2022 19:57 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Sep 2022 | Sale | 18,920 | 26.42 | 499,866 | D |
15 Sep 2022 19:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2022 | Sale | 13,986 | 28.04 | 392,167 | D |
15 Sep 2022 19:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2022 | Sale | 26,014 | 27.18 | 707,061 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 1,219 | 46.2896 | 56,427 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 5,051 | 45.3615 | 229,121 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 18,730 | 44.6606 | 836,493 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 500 | 51.4087 | 25,704 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 10,500 | 50.7291 | 532,656 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 22 Jun 2023 | Sale | 11,000 | 52.1759 | 573,935 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Jun 2023 | Sale | 11,349 | 52.2597 | 593,095 | D |
22 Jun 2023 17:20 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 20 Jun 2023 | Sale | 20,777 | 55 | 1,142,735 | D |
21 Jun 2023 17:54 | AKRO | Akero Therapeutics Inc | HEYMAN TOMAS J. | Director | 16 Jun 2023 | Sale | 26,000 | 54.6742 | 1,421,529 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,413 | 56.2966 | 79,547 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 27,462 | 55.08 | 1,512,607 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 49,325 | 54.575 | 2,691,912 | D |
21 Jun 2023 17:47 | AKRO | Akero Therapeutics Inc | HENDERSON JANE | Director | 16 Jun 2023 | Sale | 22,498 | 54.4622 | 1,225,291 | D |
21 Jun 2023 17:47 | AKRO | Akero Therapeutics Inc | HENDERSON JANE | Director | 16 Jun 2023 | Sale | 17,502 | 53.7878 | 941,394 | D |
15 Jun 2023 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Jun 2023 | Sale | 606 | 55.16 | 33,427 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Jun 2023 | Sale | 538 | 55.16 | 29,676 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Jun 2023 | Sale | 509 | 55.16 | 28,076 | D |
15 Jun 2023 21:38 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 13 Jun 2023 | Sale | 1,613 | 55.16 | 88,973 | D |
15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 May 2023 | Purchase A | 120,000 | 42 | 5,040,000 | I |
15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 Sep 2022 | Purchase A | 400,000 | 26 | 10,400,000 | I |
15 Jun 2023 21:29 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jun 2023 | Sale | 591 | 55.16 | 32,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)